Leishmaniasis Vaccine
Features of visceral leishmaniasis in BALB/c mice are described
Published in Medical Letter on the CDC and FDA, June 7th, 2006
According to a study from Spain, "It has been reported that the level of protection provided by vaccines against murine visceral leishmaniasis (VL) is low and that progress in research on VL may be due to the lack of appropriate models to study protective immunity. We have analyzed the immunohistological features occurring in BALB/c mice after intravenous administration of 103, 105, and 106 parasites of Leishmania infantum.
"Our results show that in all cases parasite...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Diabetes Epidemiology
Diabetes processes of care and intermediate outcomes have improved in U.S. - Environmental Health
Perfluorochemicals have been found in serum samples from U.S. residents - HIV/AIDS Therapy
Baseline protease genotype affects HIV response to atazanavir/ritonavir - Norovirus Diagnosis
TaqMan RT-PCR allows rapid norovirus detection, typing, and quantification - Sexual & Reproductive Health
Viagra use is linked to unprotected insertive anal sex in men who have sex with men - Adverse Drug Reaction
Bausch & Lomb responds to U.S. CDC release of data on Fusarium keratitis cases - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
